Shree Ram Proteins Faces Going Concern Doubts; Auditors Issue Adverse Opinion on Q1 FY26 Results
The auditor's adverse opinion and declaration of material uncertainty regarding the company's ability to continue as a going concern, coupled with disclosures of fund shortages, defaults, and CIRP, raise significant red flags for investors and could severely impact the company's operations and stock price.
The auditor's report explicitly states a "material uncertainty related to going concern," an "adverse opinion" on several critical financial aspects, and highlights defaults on loans and statutory dues, along with ongoing Corporate Insolvency Resolution Process (CIRP) proceedings. These indicate severe financial distress.
* The Board of Directors of Shree Ram Proteins Limited met on August 11, 2025, and approved the unaudited standalone financial results for the quarter ended June 30, 2025, along with the Limited Review Report from its Statutory Auditors. * The Statutory Auditors, H. B. Kalaria & Associates, issued a critical review report, expressing an adverse opinion on certain matters and highlighting a material uncertainty related to the company's ability to continue as a going concern. * Key concerns raised by the auditors include: * The company is facing a shortage of funds for business operations, repayment of loans, and payment of statutory dues, and has defaulted on loan repayments and statutory dues (including CSR). * Ongoing Corporate Insolvency Resolution Process (CIRP) proceedings against the company under The Insolvency and Bankruptcy Code, 2016. * Failure to carry out balance confirmations and reconciliations with debtors, creditors, and advances. * Inability to inspect inventories or physically inspect property, plant, and equipment for the review period. * Lack of impairment assessment for property, plant, equipment, inventories, advances, cash, and bank balances, and debtors. * The auditors noted that despite these issues, the company continues to prepare its financial statements on a going-concern basis, which they deem not in accordance with Ind-AS 1.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.